← Eichor
Condition: Ald Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Ald

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

LGG Supplementation in Patients With AUD and ALD
Phase 2 · 1 location(s) · University of Louisville · NCT05178069Epidural Spinal Cord Stimulation for Lower-limb Impairment in Adrenomyeloneuropathy
NA · 4 location(s) · Third Military Medical University · NCT06796920Adrenoleukodystrophy National Registry Study
Phase N/A · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT03789721UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
Phase 1 · 1 location(s) · Joanne Kurtzberg, MD · NCT02254863Quality of Life in Women with X-linked Adrenoleukodystrophy
Phase N/A · 1 location(s) · Leipzig University Medical Center · NCT04675749Health Literacy and Self-efficacy Expectations in Patients With Alcohol-related Liver Cirrhosis
Phase N/A · 1 location(s) · Hannover Medical School · NCT07169526IT and IV Lentiviral Gene Therapy for X-ALD
NA · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT03727555Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
NA · 3 location(s) · University of Wisconsin, Madison · NCT06305624Home Exercise for Individuals with Neurodegenerative Disease
NA · 1 location(s) · Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · NCT05443906Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients
NA · 13 location(s) · University Hospital, Angers · NCT05699018Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers
NA · 1 location(s) · Maja Thiele · NCT03308916Disease Progression in Women With X-linked Adrenoleukodystrophy
Phase N/A · 1 location(s) · Minoryx Therapeutics, S.L. · NCT06178120Modeling Macrophages Activation Pattern in X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy and Adult Onset L
Phase N/A · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04925349Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Phase 3 · 84 location(s) · Bausch Health Americas, Inc. · NCT07428538The Myelin Disorders Biorepository Project
Phase N/A · 23 location(s) · Children's Hospital of Philadelphia · NCT03047369Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Phase N/A · 1 location(s) · Paul Szabolcs · NCT04528355RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated
Phase 2 · 43 location(s) · Altimmune, Inc. · NCT07009860Identification of Hepatic Fibrosis Using 4D-MRI
NA · 2 location(s) · University Hospital, Basel, Switzerland · NCT05385237Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
NA · 1 location(s) · Henry Ford Health System · NCT06269510Registry of X-linked Adrenoleukodystrophy
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT05939232A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Y
Phase 2 · 131 location(s) · GlaxoSmithKline · NCT06613698A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodyst
Phase 3 · 13 location(s) · Minoryx Therapeutics, S.L. · NCT05819866A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel
Phase N/A · 3 location(s) · Genetix Biotherapeutics Inc. · NCT06224413Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD)
NA · 1 location(s) · Yale University · NCT07525258Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.
Phase N/A · 1 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT04880356Comparison of ALD, NASH, and Healthy Control Patients
Phase N/A · 1 location(s) · The Cleveland Clinic · NCT03224949Longitudinal Study of Neurodegenerative Disorders
Phase N/A · 1 location(s) · University of Pittsburgh · NCT03333200Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Phase 2 · 1 location(s) · Paul Szabolcs · NCT01962415A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis
Phase 3 · 23 location(s) · King's College London · NCT06461208
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.